Virginia Retirement Systems’s Blueprint Medicines BPMC Stock Holding History

Virginia Retirement Systems’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.55M	Buy	30,900 +5,000	+19%	+$267K	0.02%	397
2023 Q2	$1.64M	Buy	25,900 +2,400	+10%	+$130K	0.02%	402
2023 Q1	$1.06M	Buy	23,500 +1,600	+7%	+$72.1K	0.01%	534
2022 Q4	$959K	Buy	21,900 +4,900	+29%	+$235K	0.01%	615
2022 Q3	$1.12M	Buy	+17,000	New	+$1.09M	0.01%	540
2022 Q1	$1.01M	Buy	15,800 +600	+4%	+$43.1K	0.01%	637
2021 Q4	$1.63K	Sell	15,200 -11,400	-43%	-$1.19M	0.01%	495
2021 Q3	$2.73M	Sell	26,600 -4,900	-16%	-$456K	0.03%	364
2021 Q2	$2.77M	Buy	31,500 +5,200	+20%	+$476K	0.03%	369
2021 Q1	$2.56M	Buy	26,300 +9,700	+58%	+$968K	0.03%	391
2020 Q4	$1.86M	Buy	16,600 +3,900	+31%	+$411K	0.02%	420
2020 Q3	$1.18M	Buy	12,700 +7,700	+154%	+$593K	0.01%	500
2020 Q2	$390K	Buy	+5,000	New	+$338K	﹤0.01%	880
2020 Q1	–	Sell	-9,000	Closed	-$721K	–	1097
2019 Q4	$721K	Buy	+9,000	New	+$674K	0.01%	826

Other funds holding BPMC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Virginia Retirement Systems's BPMC Position: Q3 2023 in Review

Virginia Retirement Systems increased its Blueprint Medicines (BPMC) stake by 19% in Q3 2023, buying an estimated $267K and bringing the position to 30,900 shares worth $1.55M. The position accounts for 0.02% of the portfolio, ranked #397.

Virginia Retirement Systems first reported a position in BPMC in Q4 2019 and has held it in 14 quarters since. The position peaked at $2.77M in Q2 2021. 220 funds tracked by Wall St. Rank hold BPMC as of Q3 2023.

Virginia Retirement Systems held 30,900 shares of Blueprint Medicines worth $1.55M as of Q3 2023.
Virginia Retirement Systems bought 5,000 Blueprint Medicines shares in Q3 2023, an estimated $267K.
Blueprint Medicines made up 0.02% of Virginia Retirement Systems's portfolio in Q3 2023, its #397 holding.
Virginia Retirement Systems first reported a position in Blueprint Medicines in Q4 2019 and has held it in 14 quarters since.
Virginia Retirement Systems's Blueprint Medicines position peaked at $2.77M in Q2 2021.
220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.